#HVO hVIVO PLC – Positive data from novel human challenge models November 11, 2025 – Posted in: hVIVO (HVO)
hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces key insights from its scientific presentations at the 10th European Scientific Working Group on Influenza (“ESWI”) Conference in Valencia, and the World Vaccine Congress Europe in Amsterdam, which both took place in October 2025. hVIVO presented positive data from a number of newly developed human challenge models reinforcing hVIVO’s continued world-leading capabilities in accelerating…
Continue reading